Lokunia,
The Statement "RNA based technologies seeing renewed investor and Big Pharma interest" would reflect interest in the technology and predominately ISIS.
If there was still interest in either 1103 or 1102 I would have thought Mark would have been more specific i.e. investor and big pharma continue to show interest in 1103 and 1102.
As I said no indication that anyone is still interested in OUR products! This does not necessarily mean that there isn't interest, just that Mark has not said so.
I and the market would probably like to see something more specific on external interest.
investor pres announcement. , page-9
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $47.27K | 463.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 319942 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 86442 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |